Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT06393569
Recruiting Observational

Sense of Security With Access to Palliative Outpatient Clinic

NCT06393569 · tracked via the Priya Life Science Sweden tracker
Sponsor
Region Skane
Phase
Observational
Started
2024-03-14
Last updated
2026-05-13

Condition(s) studied

Cancer

Study summary

The aim of the study is to evaluate experience of security, accessibility, and avoidable utilization of health care services in patients who have had access to specialized palliative care clinic (SPCC) compared to those who have not, and to evaluate the relatives' experience of the care.

Eligibility

Sex
ALL
Min age
18 Years
Max age
120 Years
Healthy volunteers
No
Inclusion Criteria: \- Patients admitted to included ASiH-unit Exclusion Criteria: * Patients with cognitive impairment * Patients who cannot fill in a questionnaire in Swedish, Arabic or Serbo-Croatian.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
ASiH och palliativ vård Skåne Lund Sweden Recruiting

More Region Skane trials in Sweden

Febrile Infants Swedish Study Recruiting
Intractable Self-harm-What Support is Effective? Recruiting
Monitoring and Early Response Evaluation Using HPV DNA - A Study on Patients With HPV-positive Throat Cancer (MER-HPV) Recruiting
Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology Active, not recruiting
Assessment of Tiredness During Awake Resection of Intracerebral Tumors Recruiting

Other trials for the same condition

MEDECA - Markers in Early Detection of Cancer Recruiting
STATIC - Statin Termination in Cancer Recruiting
Pan Tumor Rollover Study Recruiting
Digitizing Cancer Rehabilitation During and After Systemic Treatment: Feasibility Testing Implementation in South Baltic Countries Recruiting
Effects of Oncological Treatment During Pregnancy on Mother and Child Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06393569 on ClinicalTrials.gov ↗ ← All trials in Sweden